Holen Sie sich die Stockscreener-App
80.39
0.71%
0.57
Schlusskurs vom Vortag:
$79.82
Offen:
$80.24
24-Stunden-Volumen:
109.29K
Relative Volume:
0.66
Marktkapitalisierung:
$1.82B
Einnahmen:
$213.03M
Nettoeinkommen (Verlust:
$41.32M
KGV:
43.93
EPS:
1.83
Netto-Cashflow:
$33.49M
1W Leistung:
-2.24%
1M Leistung:
-1.70%
6M Leistung:
-17.97%
1J Leistung:
-9.04%
1-Tages-Spanne:
$80.24
$82.02
1-Wochen-Bereich:
$79.60
$83.78
52-Wochen-Spanne:
$71.42
$109.58
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Firmenname
Lemaitre Vascular Inc
Sektor
Telefon
781-221-2266
Adresse
63 SECOND AVENUE, BURLINGTON, MA
Vergleichen Sie LMAT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
80.39 | 1.86B | 213.03M | 41.32M | 33.49M | 1.83 |
|
ISRG
Intuitive Surgical Inc
|
511.00 | 183.59B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
181.28 | 51.10B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
88.66 | 42.51B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
267.40 | 36.95B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
218.90 | 15.88B | 2.90B | 467.20M | 306.90M | 6.37 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-02-13 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-10-15 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2024-08-02 | Fortgesetzt | Lake Street | Buy |
| 2024-05-31 | Fortgesetzt | ROTH MKM | Buy |
| 2024-04-26 | Hochstufung | Stifel | Hold → Buy |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-06 | Eingeleitet | Oppenheimer | Outperform |
| 2023-08-03 | Herabstufung | Jefferies | Buy → Hold |
| 2023-05-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | Eingeleitet | Jefferies | Buy |
| 2021-02-12 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | Hochstufung | Sidoti | Neutral → Buy |
| 2019-10-24 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | Hochstufung | Lake Street | Hold → Buy |
| 2019-10-14 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | Bestätigt | Barrington Research | Outperform |
| 2019-07-25 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2018-06-08 | Fortgesetzt | ROTH Capital | Buy |
| 2018-04-26 | Herabstufung | Stifel | Buy → Hold |
| 2018-04-26 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2017-10-27 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-07-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-03-21 | Eingeleitet | First Analysis Sec | Overweight |
| 2017-02-22 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-07-28 | Bestätigt | Barrington Research | Outperform |
| 2016-02-25 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Lemaitre Vascular Inc Aktie (LMAT) Neueste Nachrichten
Bank of New York Mellon Corp Has $14.30 Million Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Is LeMaitre Vascular Inc. a good long term investmentOutstanding capital returns - jammulinksnews.com
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
LeMaitre Vascular Inc. Stock Analysis and ForecastFree Stock Selection - jammulinksnews.com
LeMaitre Vascular (NASDAQ:LMAT) Given "Market Perform" Rating at Barrington Research - MarketBeat
LeMaitre Vascular (LMAT) Maintains "Market Perform" Rating by Ba - GuruFocus
Why LeMaitre Vascular Inc. stock attracts strong analyst attentionFree Membership Group - Newser
Segall Bryant & Hamill LLC Acquires 17,354 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
What drives LeMaitre Vascular Inc. stock priceFree Market Dynamics Reports - Autocar Professional
What analysts say about LeMaitre Vascular Inc. stockExceptional profit margins - Autocar Professional
Bank of New York Mellon Corp Cuts Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
Alps Advisors Inc. Buys Shares of 4,220 LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Principal Financial Group Inc. Buys 3,248 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
why lemaitre vascular inc. stock attracts strong analyst attentionFree Stock Market Return Analysis - Newser
Is LeMaitre Vascular (NASDAQ:LMAT) A Risky Investment? - simplywall.st
Some Shareholders Feeling Restless Over LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) P/E Ratio - 富途牛牛
Rice Hall James & Associates LLC Sells 24,454 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Investors in LeMaitre Vascular (NASDAQ:LMAT) have seen stellar returns of 208% over the past five years - Yahoo Finance
Trend Tracker for (LMAT) - news.stocktradersdaily.com
Envestnet Asset Management Inc. Has $23.92 Million Stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
What makes LeMaitre Vascular Inc. stock price move sharplyFast Moving Stock Alerts - Newser
How LeMaitre Vascular Inc. stock performs during market volatilityFast Moving Stock Alerts - Newser
Principal Financial Group Inc. Raises Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
Teacher Retirement System of Texas Decreases Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular: High Growth Potential, But Risks Lurk Beneath the Surface - AInvest
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Allspring Global Investments Holdings LLC - Defense World
LeMaitre Will Announce Second Quarter 2025 Earnings Results August 5, 2025 - GlobeNewswire
LeMaitre Vascular, Inc. to Release Q2 2025 Financial Results on August 5, 2025 - Nasdaq
LeMaitre Sets Q2 2025 Earnings Date: How to Join the August 5 Conference Call - Stock Titan
Wealth Enhancement Advisory Services LLC Sells 494 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
Finanzdaten der Lemaitre Vascular Inc-Aktie (LMAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):